Wells Fargo Downgrades Nevro Corp (NVRO) to Equal Weight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Nevro (NVRO) Crashes 25% After Withdrawing FY Outlook, 5 Firms Downgrade as Near-Term Visibility Remains Challenged
August 5, 2021 9:52 AM EDTShares of Nevro Corp. (NYSE: NVRO) are down roughly 25% after the company reported lower-than-expected Q2 sales and lower Q3 guidance.
Nevro recorded a loss of $0.62 per share to beat the analysts expectations for a loss of $0.71 per share. However, revenues came in at $102.3 million to miss on the consensus of $104.5 million.
"The recovery of procedural volumes in the pain market generally and the SCS market specifically has been slower than we anticipated, impacting not only second quarter revenues, but in the case of lower trial procedures, revenue in future months as well," said... More
Nevro Corp (NVRO) PT Lowered to $150 at Morgan Stanley
August 5, 2021 7:35 AM EDTMorgan Stanley analyst David Lewis lowered the price target on Nevro Corp (NYSE: NVRO) to $150.00 (from $199.00) while maintaining an Overweight rating.
The analyst commented, "The guide down was a meaningful departure from expectations, yet we view the shift in outlook reflective of market... More
